Meet us at Therapeutic Oligonucleotides 2025 congress
AstraZeneca’s R&D site (Gothenburg, SE)
May 14–15, 2025
We are pleased to announce that Tebubio will attend the next Therapeutic Oligonucleotides 2025 congress organised by ELRIG, on May 14–15, 2025, at AstraZeneca’s R&D site in Gothenburg, Sweden. Let's connect with our colleague Charlotte Adler to discuss about your projects and discover how Tebubio can support your Therapeutic Oligonucleotides development.
Why meet Tebubio at EventName?
Discuss with our team to explore our unique offering:
- A comprehensive range of tools to screen, deliver and validate all your hits.
- Our Contract Research Services Lab, providing precise biomarker profiling to unlock valuable insights.
- A complementary platform for in vitro modeling and formulation screening to test your oligo on relevant research models.
- Our global expertise, covering everything from research model development to data analysis.
What is EventName about?
Attending next ELRIG congress is a unique opportunity to discuss about :
- Strategies for identifying and validating therapeutic targets, including previously inaccessible ones and non-coding genomic regions. It will highlight the role of omics technologies and computational biology, such as AI and machine learning, in facilitating these processes.
- Recent chemical advancements that enable the specific targeting of individual cell types or tissues beyond the liver. It will cover innovative strategies for delivering therapeutic oligonucleotides to extrahepatic tissues and subcellular compartments, such as endosomal escape mechanisms.
- Improving the clinical safety and efficacy of oligonucleotide therapeutics. Topics include understanding RNA interference mechanisms, off-target effects, pharmacokinetics, immunogenicity, and the development of enhanced design tools.
- Recent success stories of targeting previously undruggable targets with oligonucleotide therapeutics. It will include academic and industrial perspectives on transitioning these therapies into clinical settings, addressing various challenges and regulatory considerations.
Who will you meet on our booth?
Charlotte B. Ahler
Account Manager - Nordic Countries
